EMulate Therapeutics, Inc.
3 products found
EMulate Therapeutics, Inc. products
EMulate - Cellsana Therapeutics
Cellsana is pivotal (phase III) trial ready for treatment of Glioblastoma (GBM) and Diffuse Midline Glioma (DMG)
EMulate - Mensana Therapeutics
Mensana is feasibility (phase I) trial ready for treatment of PTSD, depression, anxiety and addiction by the application of specific psychoactive ulRFE fields, another expression of EMulate’s Therapeutic technology.
EMulate - Indolor Therapeutics
Indolor Therapeutics is feasibility (phase I) trial ready for the treatment of acute and chronic pain by the application of specific pain-managing ulRFE fields, another expression of EMulate’s Therapeutic technology.
